NOCIL Limited has informed the Exchange about Investor Presentation
NOCIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NOCIL Limited, India's largest rubber chemicals manufacturer (part of Arvind Mafatlal Group), filed its Q4 and FY25 investor presentation. FY25 revenue declined 4% YoY to Rs. 1,393 crores while net profit fell 23% to Rs. 103 crores. Operating EBITDA margin contracted sharply to 9.9% from 13.5% in FY24, reflecting pricing pressure even as sales volumes grew 4% YoY. Q4FY25 showed sequential recovery with revenue up 7% QoQ to Rs. 340 crores and EBITDA jumping 42% QoQ to Rs. 34 crores. The company announced a Rs. 250 crore capex programme for its Dahej facility and reiterated its ambition to double market share by leveraging the China+1 opportunity in exports, where volumes grew in double digits for a second consecutive year.
FY25 results show meaningful margin compression, which may weigh on sentiment despite sequential Q4 improvement. Investors may take note of the Rs. 250 crore growth capex and export-led expansion plan as positives, but the lower dividend payout (20% vs 30% earlier) and weak cash flows (net cash decline of Rs. 62 crores) suggest cautious near-term prospects.